| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/12/2001 | EP1131439A2 Maize dna ligase i orthologue and uses thereof |
| 09/12/2001 | EP1131436A1 Urotensins ii of mammals and their uses |
| 09/12/2001 | EP1131433A1 Members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
| 09/12/2001 | EP1131429A1 Calcium binding protein |
| 09/12/2001 | EP1131428A2 Immunoglobulin superfamily proteins |
| 09/12/2001 | EP1131426A2 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides |
| 09/12/2001 | EP1131425A2 Inflammation-associated genes |
| 09/12/2001 | EP1131424A2 Mutation of the parkin gene, compositions, methods and uses |
| 09/12/2001 | EP1131415A2 Low cost manufacture of oligosaccharides |
| 09/12/2001 | EP1131413A1 Immortalized brain endothelial cells |
| 09/12/2001 | EP1131411A2 Suppression of xenotransplant rejection |
| 09/12/2001 | EP1131410A1 Bioengineered tissue constructs and methods for producing and using them |
| 09/12/2001 | EP1131409A2 Method of cloning porcine animals |
| 09/12/2001 | EP1131408A2 Cells, culture methods, and their use in autologous transplantation therapy |
| 09/12/2001 | EP1131407A1 Serum free medium for chondrocyte-like cells |
| 09/12/2001 | EP1131406A2 Low oxygen culturing of central nervous system progenitor cells |
| 09/12/2001 | EP1131359A2 Coupled peptides |
| 09/12/2001 | EP1131357A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same |
| 09/12/2001 | EP1131356A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies |
| 09/12/2001 | EP1131351A2 Peptides that modulate the interaction of b class ephrins and pdz domains |
| 09/12/2001 | EP1131350A1 Egf-like nucleic acids and polypeptides and uses thereof |
| 09/12/2001 | EP1131349A2 Potassium channel interactors and uses therefor |
| 09/12/2001 | EP1131347A2 Product |
| 09/12/2001 | EP1131346A1 Heliobacter pylori antigen |
| 09/12/2001 | EP1131333A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF |
| 09/12/2001 | EP1131097A1 Anti-icam-r antibody-induced apoptosis |
| 09/12/2001 | EP1131087A2 Methods of alleviating cancer symptoms |
| 09/12/2001 | EP1131084A1 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists |
| 09/12/2001 | EP1131067A1 Composition and use of rar antagonists for promoting chondrogenesis |
| 09/12/2001 | EP1130969A1 Murf2 polypeptides and polynucleotides |
| 09/12/2001 | EP1130961A1 Stabilisation of milk from transgenic animals |
| 09/12/2001 | EP0956028B1 Submucosal tissue inhibition of neoplastic cell growth |
| 09/12/2001 | EP0839206B1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
| 09/12/2001 | EP0839006B1 Process for stabilizing proteins in an acidic environment with a high-ester pectin |
| 09/12/2001 | EP0804452B1 Recombinant c140 receptor, its agonists and antagonists |
| 09/12/2001 | EP0621898B1 Chimeric immunogens |
| 09/12/2001 | CN1312858A Bactericidal/permeability-increasing protein delation analogs |
| 09/12/2001 | CN1312723A Compound and method for diagnosis of tuberculosis |
| 09/12/2001 | CN1312372A Intocostrin regulation area and nucleotide series determination and method used thereof |
| 09/12/2001 | CN1312294A Human blood and blood vessel cytopoiesis hormone and its preparation |
| 09/11/2001 | US6288312 Generating genetically engineered plants and seeds; generate vector, coat biocompatible particle with nucleic acids, isolate embryo, transform embryo, culture embryo and detect marker in cultured plants |
| 09/11/2001 | US6288306 Methods of selecting plants, plant tissue or plant cells resistant to a protoporphyrinogen oxidase inhibitor |
| 09/11/2001 | US6288218 Detecting gene expression in sample; incubate nucleotide sequences and primers, allow hybridization and detect hybridization products |
| 09/11/2001 | US6288032 Polypeptides for osteoporosis and other bone disorder treatment |
| 09/11/2001 | US6287864 Insertion of nucleotide sequences into preferential cells; infect hematopoietic stem cells with retrovirus, detect expression of preferential gene product |
| 09/11/2001 | US6287863 Method of transferring a DNA sequence to a cell in vitro |
| 09/11/2001 | US6287860 Antisense inhibition of MEKK2 expression |
| 09/11/2001 | US6287859 Screening for transport protein modulators; incubate modulator with transport proteins, monitor effects of modulator on potassium transport |
| 09/11/2001 | US6287855 Nucleic acid encoding rat galanin receptor (GALR2) |
| 09/11/2001 | US6287852 Photosynthetic culture apparatus and group of photosynthesis culture apparatuses |
| 09/11/2001 | US6287835 Transacylases of the paclitaxel biosynthetic pathway |
| 09/11/2001 | US6287834 Characterization and use of an isolated uridine diphospho-glucuronosyltransferase |
| 09/11/2001 | US6287814 RNA export element and methods of use |
| 09/11/2001 | US6287804 nrdG |
| 09/11/2001 | US6287802 EXT2 gene |
| 09/11/2001 | US6287788 The neuropeptide galanin and its receptors hold great promise as targets for the development of novel therapeutic agents. |
| 09/11/2001 | US6287786 Nucleic acid molecules encoding a new mammalian protein and to the use of these molecules in the characterization, diagnosis, and treatment of conditions such as disorders associated with cell proliferation, lipid metabolism and transport. |
| 09/11/2001 | US6287759 Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 09/11/2001 | US6287756 Methods for determining presence of cancer in a sample by determining expression of an SSX gene |
| 09/11/2001 | US6287557 Methods of gene therapy using herpes viral vectors expressing GM-CSF |
| 09/11/2001 | US6287340 Bioengineered anterior cruciate ligament |
| 09/11/2001 | CA1341290C Method of genetically modifying plants |
| 09/07/2001 | WO2001065264A1 Trisomy 21 cytotrophoblast cultures, and uses thereof for obtaining trisomy 21 markers |
| 09/07/2001 | WO2001065262A2 Reagents and methods useful for detecting diseases of the breast |
| 09/07/2001 | WO2001065256A1 A method for detecting the reactivity of lymphocyte in blood to a specific antigen |
| 09/07/2001 | WO2001064926A2 Methods and compositions to reduce or eliminate transmission of a transgene |
| 09/07/2001 | WO2001064923A2 Vire2-mediated trans-membrane delivery systems |
| 09/07/2001 | WO2001064907A2 Lipid metabolism enzymes |
| 09/07/2001 | WO2001064903A2 Novel human transferase proteins and polynucleotides encoding the same |
| 09/07/2001 | WO2001064901A1 Beta 1, 2-xylosyltransferase-gene from arabidopsis |
| 09/07/2001 | WO2001064896A2 Human enzyme molecules |
| 09/07/2001 | WO2001064889A2 Tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 09/07/2001 | WO2001064885A1 Chordin-like-2 molecules and uses thereof |
| 09/07/2001 | WO2001064884A2 G12l, a gene associated with the thermal response |
| 09/07/2001 | WO2001064879A2 G-proteins coupled receptor related polypeptides |
| 09/07/2001 | WO2001064877A2 Human schizophrenia gene |
| 09/07/2001 | WO2001064876A2 Human schizophrenia gene |
| 09/07/2001 | WO2001064874A2 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 09/07/2001 | WO2001064870A2 Mutated cyclin g1 protein |
| 09/07/2001 | WO2001064849A1 Blood-brain barrier reconstruction model prepared by cocultivation |
| 09/07/2001 | WO2001064848A1 Method and apparatus for culturing cell or tissue |
| 09/07/2001 | WO2001064847A2 In vitro modification of cardiac valvular xenografts |
| 09/07/2001 | WO2001064846A1 Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell |
| 09/07/2001 | WO2001064845A1 A method for the selection and growth of oocytes suitable for embryonic development |
| 09/07/2001 | WO2001064844A1 Intermittent immersion vessel apparatus and process for plant propagation |
| 09/07/2001 | WO2001064843A1 Renilla reniformis green fluorescent protein and mutants thereof |
| 09/07/2001 | WO2001064838A2 Thermophilic dna polymerases from thermoactinomyces vulgaris |
| 09/07/2001 | WO2001064837A2 β NETRIN AND USES THEREOF |
| 09/07/2001 | WO2001064833A2 Ex vivo generation of functional leukemia cells in a three-dimensional bioreactor |
| 09/07/2001 | WO2001064750A2 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 09/07/2001 | WO2001064739A1 Tcf responsive element |
| 09/07/2001 | WO2001064738A2 Heparin-binding amino acid sequences derived from human proteins facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/07/2001 | WO2001064737A1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/07/2001 | WO2001064712A1 Methods for detection and treatment of neural cancers |
| 09/07/2001 | WO2001064707A1 Melanoma differentiation associated gene - 5 and promoter and uses thereof |
| 09/07/2001 | WO2001064705A1 Dna molecules encoding a glutamate-gated chloride channel in drosophila melanogaster |
| 09/07/2001 | WO2001064703A1 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/07/2001 | WO2001064247A2 Method of treating cancer with anti-neurotrophin agents |
| 09/07/2001 | WO2001064240A2 Methods for promoting production of myelin by schwann cells |
| 09/07/2001 | WO2001064238A2 Methods and compositions for regulating adipocytes |